Monday, December 24, 2012

• Biotech Portfolio Update: 2012 Summary And 2013 Outlookat Seeking Alpha (Mon, Dec 24)

Wednesday, December 12, 2012

• CURIS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and ExhiEDGAR Online (Wed, Dec 12)

Monday, December 10, 2012

• 2 Biotech Firms With Significant Upside In The Wake Of Recent Developmentsat Seeking Alpha (Mon, Dec 10)

Thursday, December 6, 2012

• Curis Announces Patents and 1 Stock Dipping to 52-Week Lowsat Wall St. Cheat Sheet (Thu, Dec 6)
• Delcath Modifies Label, Curis Receives Patent: Healthcare Business Recapat Wall St. Cheat Sheet (Thu, Dec 6)

Wednesday, December 5, 2012

• Formation Of A New Expert Group Moves Pluristem Into The Expansive Hematology Fieldat Seeking Alpha (Wed, Dec 5)

Wednesday, November 28, 2012

• Pfizer Completes NextWave Purchase, Nymox Completes Patient Enrollment: Healthcare Business Recapat Wall St. Cheat Sheet (Wed, Nov 28)
• Genentech licenses early-stage cancer drug to Curisat bizjournals.com (Wed, Nov 28)
• CURIS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation oEDGAR Online (Wed, Nov 28)

Wednesday, November 14, 2012

• Republic Airways Initiated at Outperform and 4 Initiated Shares on the Moveat Wall St. Cheat Sheet (Wed, Nov 14)

Tuesday, November 6, 2012

• Curis' CEO Discusses Q3 2012 Results - Earnings Call Transcriptat Seeking Alpha (Tue, Nov 6)
• CURIS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online (Tue, Nov 6)

Monday, October 22, 2012

• Curis: 4 Reasons To Consider This $4 Stockat Seeking Alpha (Mon, Oct 22)
• Curis: A Stock Fueled By Sonic Hedgehogat Seeking Alpha (Mon, Oct 22)

Thursday, September 27, 2012

• 4 Stocks Under $10 Making Big Movesat TheStreet (Thu, Sep 27)

Friday, September 14, 2012

• Emerging-Growth Opportunities in Oncology and Endocrinology Biotech: a Wall Street Transcript Interview with Boris Peaker of Oppenheimer & CompanyWall Street Transcript (Fri, Sep 14)

Monday, September 10, 2012

• Level 3 Deemed UNDERVALUED and 4 Stock Analyses Not to Missat Wall St. Cheat Sheet (Mon, Sep 10)
• Curis valuation compelling ahead of pipeline catalysts, says Piper Jaffraytheflyonthewall.com (Mon, Sep 10)

Friday, August 31, 2012

• 5 Pharmaceutical Companies With EMA Catalysts During The Next 3-12 Monthsat Seeking Alpha (Fri, Aug 31)

Thursday, August 16, 2012

• Curis Inc. Stock Downgraded (CRIS)at TheStreet (Thu, Aug 16)

Thursday, August 9, 2012

• CURIS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online (Thu, Aug 9)

Thursday, August 2, 2012

• CURIS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online (Thu, Aug 2)

Tuesday, June 19, 2012

• Curis: New Data Shows Efficacy In Advanced Pancreatic Cancerat Seeking Alpha (Tue, Jun 19)

Wednesday, June 6, 2012

• Roche Drug Reduces Skin Growths in Gene-Mutation Patientsat Bloomberg (Wed, Jun 6)

Friday, June 1, 2012

• CURIS INC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online (Fri, Jun 1)

Add CRIS News to My Yahoo!